The multivalent toxoid vaccine candidate from LimmaTech Biologics AG is designed to prevent skin and soft-tissue infections ...

Researchers have also found that blocking the protein reactivates immune cell function, restoring the effectiveness of ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

You may have heard of antibiotic-resistant bacterial infections, which are challenging to treat. Methicillin-resistant ...

Researchers at UC San Diego have identified a key mechanism by which Staphylococcus aureus evades the immune response, ...

In patients with Enterobacterales BSIs, early phenotype-desirable antimicrobial therapy was associated with better 30-day ...

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has grant ...

This strategy has neglected the contribution of secreted proteins to disease for decades. With the emergence of antibiotic-resistant S. aureus possessing multiple secreted virulence factors and ...

No reduction in preventing Staphylococcus aureus bacteremia in very low-birth weight (<1500 g) neonates (n = 206) No treatment effect in children ≥7 years with S. aureus bacteremia and ...